Topical skin cream for treatment of basal cell carcinoma sho
Basal cell carcinoma (BCC), a type of skin cancer, is the most common form of human cancer. With a growing aging population, BCC rates are climbing at an alarming rate, with reported cases rising by as much as 10% per year. Rising demand makes a simple and effective treatment for BCC appealing to both practitioners and patients. A new study published in the Journal of Investigative Dermatology examines the effectiveness of imiquimod, a topical skin cream used to treat low-risk BCC lesions, over a five-year period. Investigators found that imiquimod success rates were sustained for the extended study period and did not promote lesion reoccurrence....

https://www.sciencedaily.com/releases/2016/12/161213111945.htm
Like
Comment
Share